Pharmafile Logo
Pharmafocus logo
Advanced Search

Germany

Showing 15 posts of 45 posts found.

Eisai image

Eisai: Fycompa decision ‘deeply regrettable’

November 11, 2014
Research and Development, Sales and Marketing Eisai, Fycompa, Germany, epilepsy, gba, perampanel

Eisai has lashed out at a major German health assessment body, calling its stance on first-in-class epilepsy treatment Fycompa ‘deeply …

News

Boehringer spends €100 million on inhaler

September 30, 2014
Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat

Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …

News
Boehringer image

Boehringer to slash 600 jobs in native Germany

September 24, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff

Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …

News
Marijn Dekkers, Bayer chief executive

Bayer’s chief executive to step down in 2016

June 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Germany, Marijn Dekkers

Marijn Dekkers the chief executive of German pharma firm Bayer has set his departure date to the end of 2016. …

News
Germany flag

German law could see pharma discounts published

February 18, 2014
Sales and Marketing AMNOG, Germany, IMS, NICE, prices

Pharma companies are apprehensive about German lawmakers opening Pandora’s Box this week if they go ahead with plans to publish …

News
Germany image

Germany focus: strength with control

February 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE

Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …

Feature
Xarelto image

German regulator assesses more drugs

April 22, 2013
Sales and Marketing AMNOG, Bayer, Germany, Pradaxa, Xarelto

A new raft of drugs which will be subject to potentially stringent cost/benefit analysis in Germany has been announced. The …

News

Germany dismisses Seroquel XR

November 14, 2012
Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR

AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …

News

Pharma calls for urgent change in German system

June 8, 2012
Sales and Marketing AMNOG, EFPIA, Germany, Trajenta, VFA

Europe’s pharma industry has called on the German government to re-think its approach to pricing, saying it is could cause …

News
Boehringer-Lilly's Trajenta

Boehringer-Lilly won’t launch Trajenta in Germany

September 5, 2011
Sales and Marketing Drug pricing, Germany, Tradjenta, Trajenta, price cuts

Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany and say the country’s …

News

Lilly chief: German reforms jeopardise pharma innovation

July 8, 2011
Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

News

IDT Biologika expands investment in German manufacturing capacity

March 28, 2011
Manufacturing and Production Germany, IDT Biologika, vaccines

IDT Biologika has said it plans to invest around 85 million euros in new production facilities and equipment in Germany …

News

Bayer invests 35m euros in biologics production

December 14, 2010
Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production

Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …

News

Germany to cut drug prices by 2 billion euro

November 12, 2010
Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines

The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …

News

German rebates to cost pharma 1 billion euro

November 1, 2010
Sales and Marketing BPI, German pharma market, Germany, Gesetzliche Krankenversicherung, healthcare costs

The pharma industry will contribute over 1 billion euro ($1.4 billion) to Germany’s cost-containment efforts by the end of 2010. …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026